A Study of the Efficacy, Safety and Tolerability Profile of CSL Limited's Influenza Virus Vaccine (CSL's IVV) Administered Intramuscularly in Healthy Adults
Clinical trial NCT00562484 · COMPLETED
Trial details
- NCT number
- NCT00562484
- Sponsor
- Seqirus
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2009-11-01
- Enrollment
- 7500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.